Abstract C47: Association of folate receptor alpha (FRα) expression level and clinical activity of IMGN853 (mirvetuximab soravtansine), a FRα-targeting antibody-drug conjugate (ADC), in FRα -expressing platinum-resistant epithelial ovarian cancer (EOC) patients (pts)
2014 ◽
Vol 32
(15_suppl)
◽
pp. 5571-5571
◽
2016 ◽
Vol 34
(15_suppl)
◽
pp. 5567-5567
◽
Keyword(s):
2020 ◽